| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 32 | 2025 | 226 | 12.080 |
Why?
|
| Coronary Artery Disease | 19 | 2025 | 326 | 9.000 |
Why?
|
| Shock, Cardiogenic | 7 | 2026 | 108 | 5.450 |
Why?
|
| ST Elevation Myocardial Infarction | 11 | 2025 | 96 | 4.290 |
Why?
|
| Drug-Eluting Stents | 7 | 2023 | 68 | 4.260 |
Why?
|
| Myocardial Infarction | 12 | 2026 | 922 | 4.140 |
Why?
|
| Cardiac Catheterization | 11 | 2025 | 293 | 4.030 |
Why?
|
| Coronary Angiography | 15 | 2025 | 212 | 2.970 |
Why?
|
| Coronary Artery Bypass | 12 | 2025 | 292 | 2.240 |
Why?
|
| Registries | 12 | 2025 | 935 | 2.130 |
Why?
|
| Treatment Outcome | 31 | 2026 | 5834 | 2.000 |
Why?
|
| Hospital Mortality | 7 | 2026 | 881 | 1.930 |
Why?
|
| Coronary Stenosis | 4 | 2025 | 41 | 1.890 |
Why?
|
| Fractional Flow Reserve, Myocardial | 4 | 2018 | 20 | 1.800 |
Why?
|
| Heart-Assist Devices | 3 | 2026 | 158 | 1.630 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2021 | 23 | 1.600 |
Why?
|
| Coronary Vessels | 4 | 2019 | 125 | 1.480 |
Why?
|
| Stents | 7 | 2025 | 500 | 1.460 |
Why?
|
| Retrospective Studies | 24 | 2025 | 6957 | 1.450 |
Why?
|
| Aortic Valve Stenosis | 3 | 2022 | 190 | 1.450 |
Why?
|
| Time-to-Treatment | 3 | 2025 | 133 | 1.300 |
Why?
|
| Humans | 61 | 2026 | 65841 | 1.190 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 51 | 1.130 |
Why?
|
| Heart Failure | 4 | 2022 | 968 | 1.120 |
Why?
|
| Hemodynamics | 3 | 2025 | 253 | 1.030 |
Why?
|
| Male | 36 | 2026 | 31409 | 1.030 |
Why?
|
| Mortality | 2 | 2019 | 162 | 0.970 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2026 | 19 | 0.950 |
Why?
|
| Morals | 1 | 2026 | 23 | 0.950 |
Why?
|
| Risk Factors | 16 | 2025 | 5475 | 0.910 |
Why?
|
| Vascular Diseases | 3 | 2021 | 83 | 0.890 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2021 | 171 | 0.880 |
Why?
|
| Echocardiography | 2 | 2025 | 513 | 0.880 |
Why?
|
| Middle Aged | 25 | 2026 | 18500 | 0.880 |
Why?
|
| Acute Coronary Syndrome | 2 | 2023 | 254 | 0.860 |
Why?
|
| Coronary Circulation | 1 | 2025 | 55 | 0.860 |
Why?
|
| Radial Artery | 4 | 2020 | 55 | 0.840 |
Why?
|
| Leadership | 2 | 2026 | 214 | 0.840 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2025 | 50 | 0.840 |
Why?
|
| Models, Cardiovascular | 1 | 2025 | 84 | 0.830 |
Why?
|
| Atrial Appendage | 1 | 2025 | 41 | 0.830 |
Why?
|
| Coronary Thrombosis | 3 | 2018 | 21 | 0.820 |
Why?
|
| Aged | 19 | 2026 | 15147 | 0.810 |
Why?
|
| Female | 30 | 2026 | 34423 | 0.810 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 124 | 0.750 |
Why?
|
| Radiologists | 3 | 2019 | 95 | 0.740 |
Why?
|
| Respiration, Artificial | 1 | 2025 | 301 | 0.730 |
Why?
|
| Delivery of Health Care | 1 | 2026 | 439 | 0.710 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2023 | 235 | 0.700 |
Why?
|
| Quality of Health Care | 1 | 2026 | 535 | 0.700 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 143 | 0.700 |
Why?
|
| Anemia | 1 | 2023 | 132 | 0.690 |
Why?
|
| Quality Improvement | 1 | 2026 | 473 | 0.680 |
Why?
|
| Patient Discharge | 1 | 2025 | 522 | 0.680 |
Why?
|
| Cardiology | 2 | 2020 | 172 | 0.680 |
Why?
|
| Atrial Fibrillation | 2 | 2025 | 884 | 0.670 |
Why?
|
| Cardiologists | 2 | 2019 | 28 | 0.670 |
Why?
|
| Atherosclerosis | 1 | 2022 | 162 | 0.650 |
Why?
|
| Hirudins | 2 | 2019 | 12 | 0.630 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 171 | 0.630 |
Why?
|
| Middle East | 3 | 2025 | 13 | 0.620 |
Why?
|
| Ankle Brachial Index | 1 | 2019 | 14 | 0.620 |
Why?
|
| Ticlopidine | 2 | 2011 | 47 | 0.600 |
Why?
|
| Saphenous Vein | 1 | 2020 | 51 | 0.600 |
Why?
|
| Myocardial Revascularization | 2 | 2022 | 78 | 0.600 |
Why?
|
| Aneurysm | 1 | 2020 | 58 | 0.590 |
Why?
|
| Heparin | 2 | 2019 | 120 | 0.580 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 62 | 0.580 |
Why?
|
| Chest Pain | 1 | 2019 | 86 | 0.580 |
Why?
|
| Exercise Test | 2 | 2019 | 257 | 0.570 |
Why?
|
| Angina, Stable | 2 | 2016 | 11 | 0.560 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.550 |
Why?
|
| Peptide Fragments | 2 | 2019 | 419 | 0.540 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 17 | 0.530 |
Why?
|
| Predictive Value of Tests | 5 | 2025 | 1117 | 0.520 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 558 | 0.520 |
Why?
|
| Patient Care Team | 2 | 2017 | 338 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.510 |
Why?
|
| Blood Pressure | 2 | 2018 | 537 | 0.470 |
Why?
|
| Tomography, Optical Coherence | 2 | 2020 | 237 | 0.470 |
Why?
|
| Severity of Illness Index | 7 | 2025 | 1569 | 0.450 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 20 | 0.450 |
Why?
|
| Thrombosis | 1 | 2017 | 207 | 0.440 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.440 |
Why?
|
| Cicatrix | 1 | 2015 | 62 | 0.430 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 29 | 0.430 |
Why?
|
| Hemorrhage | 3 | 2023 | 287 | 0.430 |
Why?
|
| Incidence | 5 | 2020 | 1433 | 0.420 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 115 | 0.420 |
Why?
|
| After-Hours Care | 1 | 2014 | 9 | 0.420 |
Why?
|
| Candidiasis | 1 | 2014 | 49 | 0.410 |
Why?
|
| Endocarditis | 1 | 2014 | 27 | 0.410 |
Why?
|
| Embolism | 1 | 2014 | 41 | 0.410 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 214 | 0.370 |
Why?
|
| Consensus | 3 | 2020 | 175 | 0.370 |
Why?
|
| Residence Characteristics | 1 | 2014 | 230 | 0.370 |
Why?
|
| Oxygen | 3 | 2025 | 323 | 0.360 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 7 | 0.360 |
Why?
|
| Renal Circulation | 1 | 2012 | 15 | 0.360 |
Why?
|
| Ischemic Preconditioning | 1 | 2012 | 8 | 0.360 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2012 | 29 | 0.360 |
Why?
|
| Thrombectomy | 1 | 2014 | 263 | 0.350 |
Why?
|
| Time Factors | 4 | 2025 | 3779 | 0.340 |
Why?
|
| Coronary Restenosis | 1 | 2011 | 21 | 0.340 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 58 | 0.340 |
Why?
|
| Endpoint Determination | 1 | 2011 | 27 | 0.340 |
Why?
|
| Stroke Volume | 2 | 2022 | 346 | 0.320 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 284 | 0.310 |
Why?
|
| Aspirin | 1 | 2011 | 172 | 0.310 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 107 | 0.310 |
Why?
|
| Massachusetts | 5 | 2019 | 2158 | 0.300 |
Why?
|
| Physicians | 1 | 2014 | 488 | 0.270 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 22 | 0.270 |
Why?
|
| Pyrroles | 1 | 2008 | 50 | 0.270 |
Why?
|
| Physician's Role | 2 | 2019 | 122 | 0.260 |
Why?
|
| Electrocardiography | 3 | 2020 | 556 | 0.230 |
Why?
|
| Organizational Culture | 1 | 2026 | 117 | 0.220 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2025 | 61 | 0.220 |
Why?
|
| Ultrasonography, Doppler | 1 | 2025 | 29 | 0.220 |
Why?
|
| Prospective Studies | 5 | 2020 | 3340 | 0.220 |
Why?
|
| Hydrodynamics | 1 | 2025 | 43 | 0.220 |
Why?
|
| Dissection | 2 | 2021 | 47 | 0.200 |
Why?
|
| Prognosis | 3 | 2018 | 1793 | 0.200 |
Why?
|
| Prevalence | 2 | 2020 | 1454 | 0.200 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 932 | 0.190 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 2500 | 0.190 |
Why?
|
| Computational Biology | 1 | 2025 | 369 | 0.190 |
Why?
|
| Stroke | 1 | 2011 | 1225 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 162 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 1719 | 0.180 |
Why?
|
| Dobutamine | 1 | 2021 | 12 | 0.180 |
Why?
|
| Risk Assessment | 4 | 2025 | 2116 | 0.170 |
Why?
|
| Job Description | 2 | 2019 | 24 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 462 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2025 | 452 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 1663 | 0.170 |
Why?
|
| Unemployment | 1 | 2021 | 19 | 0.160 |
Why?
|
| Kidney | 1 | 2023 | 460 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 811 | 0.160 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 33 | 0.160 |
Why?
|
| Aortic Valve | 1 | 2021 | 181 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 710 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 38 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2020 | 67 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2018 | 593 | 0.150 |
Why?
|
| Antithrombins | 1 | 2019 | 16 | 0.150 |
Why?
|
| Global Health | 1 | 2020 | 181 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 170 | 0.140 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 31 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 1 | 2019 | 96 | 0.140 |
Why?
|
| Hemostatic Techniques | 1 | 2018 | 13 | 0.140 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2018 | 7 | 0.140 |
Why?
|
| Hyperoxia | 1 | 2018 | 16 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2019 | 105 | 0.140 |
Why?
|
| Punctures | 1 | 2018 | 63 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 196 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 183 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2019 | 210 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 240 | 0.130 |
Why?
|
| Logistic Models | 3 | 2017 | 1274 | 0.130 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2017 | 25 | 0.130 |
Why?
|
| Widowhood | 1 | 2017 | 5 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2017 | 1336 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 106 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 413 | 0.130 |
Why?
|
| Referral and Consultation | 2 | 2017 | 447 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 5682 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 131 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2019 | 223 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2019 | 731 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 230 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 205 | 0.110 |
Why?
|
| Theophylline | 1 | 2015 | 8 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.110 |
Why?
|
| Treatment Refusal | 1 | 2015 | 58 | 0.110 |
Why?
|
| Polysomnography | 1 | 2015 | 61 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 107 | 0.110 |
Why?
|
| Inpatients | 1 | 2017 | 322 | 0.110 |
Why?
|
| Adult | 5 | 2021 | 17578 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1060 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 462 | 0.110 |
Why?
|
| Suction | 1 | 2014 | 34 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 122 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2015 | 222 | 0.100 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2014 | 67 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 375 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2014 | 125 | 0.100 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 171 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2019 | 2651 | 0.100 |
Why?
|
| Pregnancy | 1 | 2020 | 2401 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2017 | 529 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 712 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1172 | 0.090 |
Why?
|
| Troponin | 1 | 2012 | 39 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 136 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 2739 | 0.080 |
Why?
|
| Sirolimus | 1 | 2011 | 93 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2011 | 102 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2011 | 147 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2010 | 28 | 0.080 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 22 | 0.080 |
Why?
|
| Patients | 1 | 2011 | 117 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 382 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2010 | 145 | 0.070 |
Why?
|
| United States | 2 | 2018 | 8189 | 0.070 |
Why?
|
| Myocardium | 1 | 2010 | 302 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 28 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 485 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 1281 | 0.060 |
Why?
|
| Health Promotion | 1 | 2011 | 524 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 770 | 0.060 |
Why?
|
| Liver | 1 | 2010 | 875 | 0.060 |
Why?
|
| Microcirculation | 1 | 2025 | 59 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 757 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 878 | 0.050 |
Why?
|
| Wrist | 1 | 2020 | 39 | 0.040 |
Why?
|
| Arabs | 1 | 2019 | 8 | 0.040 |
Why?
|
| Hematoma | 1 | 2020 | 85 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Specialization | 1 | 2019 | 82 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 71 | 0.040 |
Why?
|
| Workload | 1 | 2019 | 132 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 201 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 220 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2017 | 7 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2017 | 4 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 111 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 21492 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 347 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 849 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2016 | 178 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 806 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 995 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 309 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 484 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1595 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2011 | 247 | 0.020 |
Why?
|
| Cholesterol | 1 | 2011 | 262 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2322 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 463 | 0.020 |
Why?
|
| Heart | 1 | 2010 | 298 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 901 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 864 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 618 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 970 | 0.010 |
Why?
|